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Background: Trauma often cooccurs with cardiac arrest and hemorrhagic shock. 
Skin and muscle injuries often lead to significant inflammation in the affected tissue. 
The primary mechanism by which inflammation is initiated, sustained, and terminated is 
cytokine-mediated immune signaling, but this signaling can be altered by cardiac arrest. 
The complexity and context sensitivity of immune signaling in general has stymied a clear 
understanding of these signaling dynamics.
Methodology/principal findings: We hypothesized that advanced numerical and 
biological function analysis methods would help elucidate the inflammatory response to 
skin and muscle wounds in rats, both with and without concomitant shock. Based on 
the multiplexed analysis of inflammatory mediators, we discerned a differential interleukin 
(IL)-1α and IL-18 signature in skin vs. muscle, which was suggestive of inflammasome 
activation in the skin. Immunoblotting revealed caspase-1 activation in skin but not 
muscle. Notably, IL-1α and IL-18, along with caspase-1, were greatly elevated in the 
skin following cardiac arrest, consistent with differential inflammasome activation. 
conclusion/significance: Tissue-specific activation of caspase-1 and the NLRP3 
inflammasome appear to be key factors in determining the type and severity of the 
Abbreviations: BRD, band relative density; CTA, composite tissue allotransplantation; df, degrees of freedom; F, F-statistic 
(ratio of the between-group and within-group mean squares); FAN, confirmatory factor analysis; “injury only,” excisional 
wound group; LPS, lipopolysaccharide; MS, mean squares (the ratio SS/df); NMR, nuclear magnetic resonance; PCA, principal 
component analysis; PMN, polymorphonuclear neutrophil; “shock associated with cardiac arrest,” cardiac arrest group; SS, 
sum of squares.
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inTrODUcTiOn
Healthy skin and muscle tissue exist in a steady-state equilib-
rium that is characterized in large part by the absence of acute 
inflammation (1). When injured, the tissue’s steady state is upset, 
inducing a cascade of responses that include inflammation, 
repair, and remodeling of the affected region. The inflammatory 
response is an essential part of successful wound healing and sets 
the stage for effective repair and remodeling (2). The composition 
of the underlying inflammatory/immune signaling that drives the 
inflammatory response to injury is therefore critical in determin-
ing whether the inflammation ultimately leads to successful 
healing or instead leads to additional damage and dysfunctional 
tissue healing. However, when inflammatory signaling propor-
tional to an injury is altered, the inflammatory response does 
not successfully transition to subsequent stages of tissue healing 
(3). Significant systemic insults, such as cardiac arrest, have the 
potential to drastically alter local immune signaling activity and 
possibly disrupt wound healing. To the best of our knowledge, the 
effect of cardiac arrest on these local wound-healing-associated 
immune signaling processes has not been elucidated.
In the setting of both civilian and military trauma, severe local 
tissue injury can often be accompanied by cardiac arrest (4–7). 
Cardiac arrest affects numerous physiological processes, as well as 
setting in motion systemic inflammation (8–11). Although short-
term hypoxia may be an important part of stimulating wound 
healing (12), severe or extended disruption of oxygen supply 
interferes with successful wound healing (13). We hypothesize 
that the specific local inflammatory mediator network patterns 
expressed during the initial inflammatory response contain 
information about how the immune system is responding to a 
localized injury, and whether the response is leading to successful 
or dysfunctional healing outcome.
Cardiac arrest, even with eventual sudden restoration of blood 
flow, is known to cause significant cellular stress, the buildup of 
toxins, and the release of endogenous danger signals that can 
promote inflammation. In the neurological context, cardiac arrest 
is particularly well understood to cause a great deal of damage to 
nerves. Therefore, we further hypothesize that the eventual sud-
den restoration of blood flow will in essence create an ischemia/
reperfusion milieu characterized by the further release of inflam-
matory mediators, which will have a further deleterious effect on 
properly localized and moderated wound healing.
The domain of wound healing has been extensively studied 
with many excellent articles and reviews that provide an overview 
of the phases, cellular processes, and molecular signals that have 
been observed in various wound-healing settings (2, 14–18). 
The effect of the insult of cardiac arrest on patient outcomes has 
been studied with respect to the impact on patient survival and 
neurological damage, with significant focus on the potential pro-
tective effects of induced mild hypothermia (19–22). However, to 
the best of our knowledge, no prior studies examine the effect that 
cardiac arrest may have on the local immune signaling processes 
essential to inflammation and wound healing.
Analysis and interpretation of the immune signaling process 
that drives inflammation is challenging because of the complex 
interplay among inflammatory mediators and their sensitive 
dependence on local and systemic conditions. Consequently, 
analysis of the progression of inflammation must leverage analytic 
methods and the insights that are capable of robustly assessing 
multiple dimensions of variance simultaneously, and of obtaining 
relevant information from high-dimensional data matrices (23).
A variety of data analysis methods suitable to exposing the 
internal structure of such noisy, high-dimensional data have been 
developed and utilized extensively for the analysis of complex 
systems in areas such as computational linguistics and machine 
learning (24). We and others have suggested the need to employ 
data-driven computational modeling in order to derive insights 
from the types of high-dimensional datasets obtained when 
studying complex biological system, such as the inflammatory 
response (25–27). We have explored multiple techniques for 
visualizing and enumerating salient features of acute inflamma-
tion in both preclinical and clinical settings, thus providing some 
insight into the types of analytic methods likely to be effective in 
elucidating key aspects of the observed inflammatory response 
(25, 28–37).
In the present study, we investigated patterns of immune 
signaling induced in vivo in rat skin and muscle following tissue 
injury in the form of excisional wounding. We then carried out 
in  silico analyses to define principal drivers of local inflamma-
tory responses, in the presence or absence of cardiac arrest. We 
demonstrate that tissue-specific immune signaling patterns are 
modified by cardiac arrest (also a paradigm of severe hemorrhagic 
shock) and suggest that inflammasome activity may govern the 
type of inflammation initiated.
MaTerials anD MeThODs
rat Model of Tissue injury
To simulate tissue injury, we carried out deep tissue excisional 
biopsies of skin and muscle (38, 39). All animal procedures, care, 
and housing were reviewed and approved by the University of 
Pittsburgh Institutional Animal Care and Use Committee and 
followed the National Institutes of Health guidelines for the care 
and use of laboratory animals. We divided the study into two 
experimental groups: injury only (injury group) and injury with 
cardiac arrest (cardiac arrest group). In the “injury group,” four 
Lewis rats were anesthetized, and an excision biopsy was taken 
inflammatory response to tissue injury, especially in the presence of severe shock, as 
suggested via data-driven modeling.
Keywords: inflammasome, inflammatory mediators, computational modeling, data driven modeling, cardiac 
arrest and trauma, immunoregulatory, localized tissue injury, hemorrhagic shock
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from the lateral aspect of the thigh on one of the hind limbs in 
each of the rats. Tissue was drawn away from the body and held 
in forceps while surgical scissors cut 15 mm × 10 mm of tissue 
from the lateral aspect of the thigh. In the “cardiac arrest group,” 
four Lewis rats were sacrificed with a fatal sodium pentobarbital 
(Lundbeck Inc., Deerfield, IL, USA) overdose, and excision 
biopsy taken 15–30 s after cessation of heartbeat.
Protein isolation and sample Preparation
We have previously shown the preservation of animal and 
human tissues in RNALater™ (Ambion, Austin, TX, USA) 
is a method compatible with subsequent Luminex™ analysis 
(40–42). Accordingly, all tissue samples were sectioned into 
≤0.5  cm3 pieces and placed into individual sample tubes filled 
with RNALater™ and stored as per manufacturer instructions 
and as determined empirically in our prior study (40). For tissue 
processing, approximately 50 mg of the tissue was transferred to 
a 2-ml microcentrifuge tube containing 0.6 ml of 1× BioSource™ 
(Invitrogen, San Diego, CA, USA) tissue extraction reagent sup-
plemented with 10 μl of 100mM phenylmethanesulfonyl fluoride 
in ethanol as a protease inhibitor. The tissues were then homog-
enized using a tissue homogenizer, then centrifuged at 4°C for 
10 min at 10,000 × g. After centrifugation, the supernatant were 
collected and assayed for protein content using the bicinchoninic 
acid (BCA) protein assay (Pierce, Rockford, IL, USA) as per 
manufacturer’s protocol.
assays for inflammation Biomarkers
All samples were assayed for inflammatory cytokines and 
chemokines using the Luminex™ multiplexing platform (100 
IS; MiraiBio, Alameda, CA, USA) and a Millipore™ 14-plex rat 
cytokine bead set (Millipore, Billerica, MA, USA) that included 
interferon (IFN) γ, interleukin (IL)-1α, IL-1β, IL-2, IL-4, IL-5, 
IL-6, IL-10, IL-12p70, IL-18, monocyte chemotactic protein 
(MCP-1), GRO/KC, TNFα, and granulocyte-macrophage colony-
stimulating factor (GM-CSF). Results were read in picogram per 
milliliter, then subsequently normalized to total mass of sample 
protein (picogram of cytokine/milligram of protein) for each of 
the 14 cytokines by the formula x = (a/b) × 1000, where x = (pico-
gram of cytokine/milligram of protein), a = (picogram per mil-
liliter of cytokine), and b = (microgram per milliliter of protein).
For immunodetection of caspase-1, protein samples (25 μg) 
were separated on 12% SDS-polyacrylamide gels, and the gels were 
electroblotted onto PVDF membranes. After overnight blocking, 
the membranes were incubated overnight with a rabbit polyclonal 
antibody from Abcam (Cambridge, MA, USA) at 4°C followed by 
1 h incubation with a goat antirabbit secondary antibody from 
Pierce (Rockford, IL, USA) at room temperature. Bands were 
detected using the Supersignal™ West Dura Extended Duration 
Substrate Chemiluminescent kit as per the manufacturer instruc-
tions. All readings are for active caspase-1 (20 kDa).
For Coomassie blue staining, the same procedure was followed 
as for acrylamide gels (4–15%), then stained with Bio-safe™ 
(BioRad, Hercules, CA, USA) stain. After washing, 50 ml of Bio-
safe™ Coomassie stain was added. After shaking for 1 h, the pro-
tein bands became visible within 20 min and reached maximum 
intensity within 1  h. Skin to muscle caspase-1 expression was 
calculated by dividing the measured band relative density (BRD) 
ratio of skin with the measured BRD ratio of muscle: r =  s/m, 
where s = skin BRD, m = muscle BRD, and r = ratio of skin BRD 
to muscle BRD. SEM was calculated for each group.
statistical and computational analyses
Statistical analyses were performed using Math Works MatLab™, 
Microsoft Excel™, and SAS Stat View™. Western blot quantifica-
tions were compared using a balanced one-way ANOVA with 5% 
significance. Cytokine quantifications were compared utilizing 
an unpaired one-tailed heteroscedastic t-test, again with a 5% 
significance level.
Principal component analysis (PCA) (26) was used to 
help discern which of the 14 proinflammatory cytokines and 
chemokines measured by Luminex™ are the most informative 
with regards to the observed immune response, similar to 
methodology we have used previously in the context of murine 
trauma/hemorrhage (25). Data were grouped by tissue (all skin 
samples and all muscle samples), and linear combinations of 
the original 14 dimensions (cytokines/chemokines) in each 
group were created in order to produce synthesized latent 
variables that explain >95% of the variance observed. The 
strength of each inflammatory mediator’s contribution to each 
of the principal components was also examined, in order to 
provide additional evidence for determining which cytokines/
chemokines could be considered to be driving the observed 
immune reactions (25).
Immune signaling is driven to a large extent by the local 
inflammatory mediator milieu. While methods, such as PCA, 
are able to identify mediators that contribute the most variance 
to the observed immune response, it is essential to place these 
numerical results in biological context. Therefore, the PCA was 
combined with a confirmatory factor analysis (FAN) to elucidate 
the relevant pathways of the observed immune response. As a part 
of the FAN, the published literature was examined for descrip-
tions of the similarities and differences in the known biological 
properties of the cytokines identified through PCA, in order to 
find common or complimentary patterns of function. Groupings 
of inflammatory mediator contributions to components one and 
two in the PCA were interpreted as latent factors and used as the 
basis for FAN. FAN seeks to model the observed variables as lin-
ear combinations of the provided potential factors. This form of 
analysis is based on regression modeling, and therefore provides 
additional weight to similar evidence found through PCA when 
there is similarity in the results.
While factor analysis is related to PCA, the two analyses are 
not identical. PCA takes a linear combination of the observed 
variables to derive synthesized latent variables; however, factor 
analysis takes the conceptually opposite approach. Using regres-
sion techniques, this method models the observed variables 
through linear combinations of potential latent variables that 
are provided. When the two methods produce models that are 
in agreement or similar, we interpret this as suggestive evidence 
that the latent variables are indeed playing an influential role in 
the observed pathology.
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The literature-based analysis is a process by which we have uti-
lized previously published studies that elucidate the mechanisms 
or behaviors of the signaling proteins under analysis. We extract 
the biological functions described as associated with the proteins 
and use those functions as labels in our feature transformation 
and factor analysis work. We believe that this is an efficient 
evidence-based method to describe what signaling proteins the 
transformation and factor analysis methods are emphasizing as 
important and putting them into a narrative that describes what 
role they are likely fulfilling in context.
resUlTs
As a paradigm of localized tissue injury, excisional biopsies were 
made on the lateral aspect of the thigh on Lewis rat hind limbs, 
as described in Section “Materials and Methods.” To elucidate 
changes in the immune signaling profile that occur at the ces-
sation of heartbeat, cardiac arrest was induced as described 
in Section “Materials and Methods.” The testing of the second 
hypothesis stated in the introduction is through samples collected 
within 30 s of cardiac arrest, within a timeframe that is common 
in trauma-associated cardiac arrest events.
Samples taken from the wounded areas of skin and muscle 
were found to have significantly different levels and patterns 
of inflammatory mediator expression. These differences were 
evident across groups as well as across tissue.
In skin, the levels of IL-18 and IL-1α present in “cardiac arrest 
group” animals (Figure 1A) were much higher than those seen 
in any other groups. MCP-1, GM-CSF, IL-10, IL-6, and IL-1β 
were all also elevated in the “injury group” animals (Figure 1B). 
In muscle, similar differences between “cardiac arrest group” 
animals (Figure 1C) and “injury group” (Figure 1D) were also 
seen, along with marked increases in IL-18, IL-1α, IL-6, IFNγ, 
and MCP-1.
The presence of IL-18 and IL-1β led us to hypothesize the pres-
ence and activation of the NLRP3 inflammasome in response to 
localized tissue injury and cardiac arrest. To test this hypothesis, 
we examined the expression of caspase-1, which is required for 
inflammasome activity (43). As determined by Western blot-
ting analysis, caspase-1 was present in both skin and muscle in 
all study groups (Figures  2A,B). This finding, in combination 
with the presence of IL-18 and IL-1β, strongly indicates NLRP3 
inflammasome activity. Similar levels of caspase-1 expression 
were found in both the skin (Figure 2C) and muscle (Figure 2D) 
of “injury group” animals, implying relatively equal levels of 
inflammasome activation. In contrast, “cardiac arrest group” ani-
mals expressed significantly more caspase-1 in skin than muscle, 
by approximately a factor of 12.
“Cardiac arrest group” skin was associated with elevated levels 
of caspase-1 and IL-18. In “cardiac arrest group” muscle, IL-18 
levels were also markedly increased; however, caspase-1 levels 
were lower than in “injury group” muscle.
Whereas significant inflammatory mediator concentration 
differences in the skin were observed between the “injury group” 
and “cardiac arrest group,” the levels were consistently higher in 
the “cardiac arrest group” animals (Figures  3B–G). The single 
exception was GM-CSF, which was present at a much higher 
concentration in the skin of “injury group” animals (Figure 3A). 
In “cardiac arrest group” animals, the cytokine with the highest 
differential elevation relative to “injury group” animals was IFNγ. 
The only cytokine elevated differentially between groups within 
muscle tissue was IL-18, whose expression was considerably 
higher in “cardiac arrest group” animals (Figure 3N).
Also notable was the contrast between skin and muscle tissue 
inflammatory mediator profiles, particularly within the “injury 
group” (Figures 3H–Q). Interestingly, the “injury group” animals 
displayed a much wider range of statistically significant differ-
ences in the expression of cytokines and chemokines between 
skin and muscle tissue as compared to “cardiac arrest group” ani-
mals. Although the concentration of many of these inflammatory 
mediators was actually higher in “cardiac arrest group” animals, 
the difference between skin and muscle tissue expression of each 
cytokine was much smaller. IL-4, IL-12p70, and TNFα were 
expressed at significantly different levels between skin and muscle 
tissues within the “cardiac arrest group” animals (Figures 3O–Q). 
These expression levels are also distinct from any inflammatory 
mediators within the “injury group,” revealing distinct immune 
signaling patterns in the two groups.
Principal component analysis synthesized two latent variables 
in skin (Figure 4A) and in muscle (Figure 4B). In skin, the first 
principal component was comprised mostly of IL-18 and IL-1α, 
while the second component was comprised of IL-18, IL-6, 
MCP-1, IL-1β, and GRO/KC (Figure  4C). The first principal 
component of muscle was also primarily made up of IL-18 and 
IL-1α, whereas the second principal component was mostly com-
prised of IL-6, IL-18, MCP-1, and GRO-KC (Figure 4D). TNFα 
and IL-4 were identified as important cytokines in both “cardiac 
arrest group” skin and muscle and are known to play a role in 
many immune regulation or intercellular signaling contexts 
(44–46). Although the contribution of each of these cytokines is 
similar in the first principal component, their contributions were 
substantially different in the second principal component. This 
finding suggests that the cytokines are complementary in some 
respects but have distinct roles in the inflammatory mediator 
network.
Principal component analysis suggested a potential role for 
GM-CSF in tissue injury (but not shock) skin. The converse was 
observed in the case of the chemokine MCP-1 (CCL2), which 
was highly expressed in the skin of “cardiac arrest group” animals, 
but expressed at far lower levels in the skin of the “injury group” 
animals. Furthermore, high levels of IFNγ were observed in the 
“cardiac arrest group” animals, while IFNγ was entirely absent 
from the “injury group” animals.
Two-factor analysis of the skin generated a model of cytokine/
chemokine contributions to the latent variables that was very 
similar to the representation derived by PCA (Figure 5A). Two-
factor analysis of the muscle yielded a model that has similarities 
with the model derived by PCA; however, the overall agreement 
of the two models is not as strong as found in skin (Figure 5B). 
The functions of inflammatory mediators most heavily influenc-
ing each factor were correlated with descriptions of their biologi-
cal function from the literature, and through this analysis labels 
for the latent variables, which were established as “macrophage 
activation” and “cell-mediated cytotoxic response.”
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DiscUssiOn
inferring inflammasome-Driven networks 
from Data-Driven Modeling
In the present study, we sought to elucidate immune/inflamma-
tory signaling patterns in the response to skin and muscle dam-
ages, in the presence or absence of cardiac arrest. We reasoned 
that this would represent an important step in understanding the 
potential mechanisms that drive immunological responses to tis-
sue damage at the earliest stages in the settings of complex injury.
In the present study, we hypothesized that application of 
high-dimensional feature transformation methods, combined 
with biological knowledge from reports in the literature, can 
provide a deeper understanding of the immune signaling pro-
cesses that underlie injury-associated inflammation. Based on 
the multiplexed analysis of inflammation biomarkers coupled 
with data-driven modeling, we suggest that tissue injury leads to 
the differential induction of IL-1α and IL-18 in skin vs. muscle. 
This inflammatory profile is associated with elevated caspase-1 
FigUre 1 | cytokine expression in skin and muscle tissue: “cardiac arrest group” vs. “wound group.” The concentration of each cytokine in skin tissue in 
the “cardiac arrest group” (a) and the “wound group” (B) and in muscle tissue [“shock” (c) and the “wound group” (D)] across all time points, measured by 
Luminex™ as described in Section “Materials and Methods.” Cytokine concentrations are expressed in picogram per milligram total protein.
immunoblotting in skin but not muscle. Cardiac arrest greatly 
elevates IL-1α, IL-18, and caspase-1 in the skin. Thus, inflam-
masome activity appears to be central to the type and severity of 
the inflammatory response to local tissue injury, and this activity 
appears to be augmented greatly in the presence of cardiac arrest.
We utilized PCA in the current study, because this method 
is capable of quantifying the amount of information contributed 
by individual cytokines to the observed inflammation (25, 47, 
48). Because this method evaluates the contribution of new 
information derived from each inflammatory mediator to each 
of the inflammatory processes observed, PCA assigns the highest 
scoring to cytokines most correlated with a specific inflammatory 
response. As utilized herein, PCA seeks to find the linear combina-
tion of the original 14 inflammatory mediators that captures the 
most variance in the smallest number of synthesized variables. 
Thus, since PCA can show which combination of inflammatory 
mediators lies in a particular principal component, this method 
can suggest inflammatory networks which interact together to 
drive a particular facet of the overall response.
FigUre 2 | caspase-1 expression in skin and muscle tissue: “cardiac arrest group” vs. “wound group.” Skin and muscle samples from both experimental 
groups (“cardiac arrest group” and “wound group”) were processed for protein isolation followed by Western blotting and analysis for active caspase-1 protein and 
Coomassie blue staining for loading control (see Materials and Methods). (a,B) Show a Western blot for caspase-1 in the “wound group” (W) and the “cardiac arrest 
group” (S), respectively. The numbers represent the sample from the individual animals in each group (n-4). Densitometric analysis of Western blots for active 
caspase-1 in skin (c) and muscle (D) (P < 0.05, as determined by one-way ANOVA).
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Although a well-established numerical analysis method, 
additional evidence to support the interpretation of PCA results 
is desirable and can be provided by FAN (49–51). PCA and FAN 
are related methods and can intuitively be understood as provid-
ing confirmatory analysis. While PCA is based on variance, FAN 
takes as the input the number of hypothesized factors driving 
the observed process and then seeks to find the optimal linear 
coefficients for each cytokine to project from the hypothesized 
factors back to the original values measured for each cytokine. In 
short, PCA reduces the dimensionality of a given dataset, while 
FAN expands that dimensionality. In both cases, the effect is to 
expose the orthogonal aspects of the data in order to gain a better 
perspective of what measured parameters are most responsible 
for driving the observed process, which in the present study is 
inflammation. When the two methods produce coefficient scores 
for the inflammatory mediators that are similar to each other, 
this can be interpreted as evidence in support of the hypothesis 
that inflammation is, to some degree, driven by those particular 
mediators. However, if the two methods produce coefficient scores 
that do not agree, it is likely that the number of hypothesized fac-
tors is insufficient to capture the complexity of the inflammatory 
process.
Using such dimensionality reduction methods, we have previ-
ously inferred principal characteristics or drivers of inflammation 
in mice subjected to surgical trauma alone vs. that same trauma 
in combination with hemorrhagic shock (25). More recently, we 
have utilized PCA to suggest a key module in a multicompart-
ment mechanistic mathematical model of inflammation and 
organ pathophysiology in endotoxemic swine (48), to suggest key 
physiologic effects of peritoneal suction as a therapy for sepsis 
(32), to connect in vitro and in vivo outcomes in the inflammatory 
response to implanted biomaterials (28), as well as suggesting 
key changes in metabolism that occur in the setting of pulsatile 
perfusion of livers prior to transplantation (29). Importantly, we 
have recently used these methods to suggest a role for the inflam-
masome (including elevated IL-18 and caspase-1) in a rat model 
of chronic neuropathic pain (42).
To better understand the observed immune signaling activity, 
we investigated two classes of insult: tissue injury only and tissue 
injury with shock. In the first model, the inflammatory response 
to surgically excised wounds in skin and muscle tissue without 
any secondary contaminants reveals immune signaling patterns 
primarily associated with wound healing. In the model of injury 
with shock, changes in the patterns of the inflammatory response 
FigUre 3 | cytokine levels in “wound group” vs. “cardiac arrest group” and in skin vs. muscle tissue. Tissue protein-normalized cytokine concentrations 
in “wound group” vs. “cardiac arrest group” (a–g) and in skin vs. muscle tissue (h–Q). The concentrations of each cytokine were measured by Luminex™ as 
described in Section “Materials and Methods” and are expressed in picogram per milligram total protein. *P < 0.05 by one-tail heteroscedastic t-test.
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Using such dimensionality reduction methods, we have previ-
ously inferred principal characteristics or drivers of inflammation 
in mice subjected to surgical trauma alone vs. that same trauma 
in combination with hemorrhagic shock (25). More recently, we 
have utilized PCA to suggest a key module in a multicompart-
ment mechanistic mathematical model of inflammation and 
organ pathophysiology in endotoxemic swine (48), to suggest key 
physiologic effects of peritoneal suction as a therapy for sepsis 
(32), to connect in vitro and in vivo outcomes in the inflammatory 
response to implanted biomaterials (28), as well as suggesting 
key changes in metabolism that occur in the setting of pulsatile 
perfusion of livers prior to transplantation (29). Importantly, we 
have recently used these methods to suggest a role for the inflam-
masome (including elevated IL-18 and caspase-1) in a rat model 
of chronic neuropathic pain (42).
To better understand the observed immune signaling activity, 
we investigated two classes of insult: tissue injury only and tissue 
injury with shock. In the first model, the inflammatory response 
to surgically excised wounds in skin and muscle tissue without 
any secondary contaminants reveals immune signaling patterns 
primarily associated with wound healing. In the model of injury 
with shock, changes in the patterns of the inflammatory response 
FigUre 3 | cytokine levels in “wound group” vs. “cardiac arrest group” and in skin vs. muscle tissue. Tissue protein-normalized cytokine concentrations 
in “wound group” vs. “cardiac arrest group” (a–g) and in skin vs. muscle tissue (h–Q). The concentrations of each cytokine were measured by Luminex™ as 
described in Section “Materials and Methods” and are expressed in picogram per milligram total protein. *P < 0.05 by one-tail heteroscedastic t-test.
FigUre 4 | Principal component analysis suggests distinct groups of inflammatory mediators induced in the “wound group” vs. the “cardiac arrest 
group” in skin and muscle. (a) Percentage of variance explained by principal components in skin. Over 95% of the variance observed in skin can be explained by 
two latent variables, formed through linear combination of the original 14 variables (cytokines). Latent variables eliminate redundant information and identify the 
cytokines that are most informative about the observed immune response. (B) Percentage of variance explained by principal components in muscle. Over 95% of 
the variance observed in muscle can be explained by two latent variables, formed through linear combination of the original 14 variables (cytokines). (c) Principal 
component variable composition in skin. Each vector represents a cytokine’s contribution to each of the first and the second principal components. The lengths of 
the vectors indicate the strength of that cytokines contribution, and the direction indicates the proportion of principal component it is contributing to. This figure 
represents these relationships in the skin. (D) Principal component variable composition in muscle. This figure represents the strength of each measured cytokine’s 
contribution to each of the first and the second principal components, in muscle.
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to surgically incised wounds under conditions of cardiac arrest 
represent the disruptive effect of a disruption in blood flow and 
the associated stresses have on wound-healing signaling. Changes 
in immune signaling under these circumstances are caused by 
metabolic stress and other factors accompanying shock.
In the present study, we observed elevations in a wide range of 
proinflammatory mediators, including IL-1α, IL-1β, IL-4, IL-6, 
IL-12, IL-18, MCP-1, and TNFα. These networks of inflammatory 
mediators, observed in both the “injury group” and the “cardiac 
arrest group” are indicative of highly activated immune cells, 
such as dendritic cells, mast cells, and neutrophils. Dendritic cells 
are known as sensitive and potent pathogen presentation cells, 
but they are also becoming recognized as important in wound 
detection and healing in a variety of contexts (52–54). The specific 
role of these immune cells in a tissue is affected by the cytokine 
milieu present (23, 55). Importantly, most of these mediators have 
been implicated in the response to trauma/hemorrhage, in prior 
studies, especially TNFα (56–59) and MCP-1 (31, 35).
Although the specific milieu of the “injury group” and “cardiac 
arrest group” animals appeared distinct, PCA and FAN suggested a 
central role for IL-1α and IL-18, leading us to hypothesize and con-
firm the concomitantly elevated expression of activated caspase-1 
as evidence for strong inflammasome activation in these tissues. As 
cells are killed, are damaged, or are induced into apoptosis by the 
wounding process, they release endogenous damage-associated 
molecular pattern (DAMP) molecules, such as uric acid crystals 
FigUre 5 | Factor analysis suggests distinct groups of inflammatory mediators induced in the “wound group” vs. the “cardiac arrest group” in skin 
and muscle. (a) Factor analysis (two factors) variable composition in skin. Modeled cytokine contribution to “cell-mediated cytotoxic response” and “macrophage 
activation” as calculated by linear combinations of provided latent factors. The direction of each vector indicates which factor the cytokine influences, while the 
length indicates the relative strength of influence as calculated by the model. (B) Factor analysis (two factors) variable composition in muscle. Modeled cytokine 
contribution to “macrophage activation” and “cell-mediated cytotoxic response” as calculated by linear combinations of provided latent factors.
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and high-mobility group protein B1 (HMGB1), molecules that 
trigger inflammatory response mechanisms (60–64). One DAMP-
induced mechanism of particular relevance to the inflammatory 
signaling profile observed in this study involves the activation of 
the NLRP3 inflammasome (65), which is one of several multipro-
tein complexes that play important roles in inflammation and cell 
death (66). Deficiency or overactivation of these cytoplasm-based 
protein assemblies has been implicated in inflammation-associated 
damage in a variety of disorders (67), and inflammasome activation 
is widely regarded as critical in the initiation of the innate immune 
response. NLRP3 responds to DAMPs and involves a spontane-
ous protein assembly that forms primarily in the cytoplasm of 
macrophages, monocytes, some keratinocytes (65), and mast cells 
(68). The NLRP3 inflammasome is known to respond to cytokines 
as well as DAMPs including HMGB1 and uric acid crystals (69). 
The inflammasome, in turn, produces and secretes bioactive proin-
flammatory cytokines. This process initiates an inflammation and 
wound-healing cycle that may moderate and conclude successfully 
with functional wound healing or may lead to runaway inflamma-
tion resulting in dysfunctional wound healing (68).
Although all classes of inflammasome produce proinflamma-
tory cytokines, each assembly only forms in response to specific 
stimuli. In the present study, we found evidence for the activation 
of NLRP3 (cryopyrin, NALP3) inflammasome. This inflam-
masome forms specifically in response to the types of DAMPs 
released in wounding and shock, as well as pathogen-associated 
molecular patterns (PAMPs) (70, 71). This class of inflammas-
omes leads to the recruitment of caspase-1 and the cleavage 
of pro-IL-1β and pro-IL-18 to yield the bioactive, proinflam-
matory cytokines IL-1β and IL-18. These cytokines are able to 
induce degranulation in polymorphonuclear neutrophil (PMN) 
leukocytes (72). Importantly, caspase-1 activity appears to be 
essential for the innate immune response, given that caspase-
1-deficient mice are resistant to developing shock in response to 
PAMPs, such as LPS (73).
NLRP3-depleted mice produce neither IL-1β nor IL-18 but 
are still able to express IL-1α, IL-12p40, and TNFα (74). In the 
present study, we found large quantities of IL-1α in wounded skin 
across all groups, suggesting that the observed immune response 
may in fact be comprised of several components that are driven 
by different activation and signaling pathways. Furthermore, we 
observed larger quantities of IL-18 vs. IL-1β, in line with reported 
requirement for prestimulation, for example with LPS, for the 
detection of large quantities of IL-1β (73). These findings are also 
in line with our recent studies in a rat model of chronic constric-
tion injury and neuropathic pain (42).
In addition to inflammasome-derived cytokines, analysis of 
the biological functions of the cytokines identified by PCA sug-
gested other potential mechanisms of inflammation induced by 
skin injury and cardiac arrest. For example, GM-CSF was highly 
expressed in skin in the “injury group” animals, while this cytokine 
was relatively absent in the “cardiac arrest group” animals. Since 
GM-CSF is an important regulator of macrophage and granulo-
cyte populations and has been shown to play an important role in 
the onset and propagation of inflammation (75, 76), its presence 
indicates strong macrophage recruitment and host defense or 
inflammatory activity. Thus, we hypothesize that GM-CSF plays 
a key role in the phenotype of the skin of the “injury group,” a 
role which we hypothesize is supported by cytokines, such as 
TNFα and IL-4. Numerous reports on the healing properties of 
GM-CSF in the literature support our PCA-derived hypothesis 
for the role of GM-CSF in the “injury group” (77–82).
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In muscle, IL-6, IL-18, and IL-1α shared both direction and 
strength of influence in both PCA and FAN models of muscle. 
Interestingly, we have suggested that MCP-1 in some way controls 
IL-6 expression (31), and it was notable that MCP-1 figured in 
both PCA and FAN. Additionally, GM-CSF and IL-1β were 
influential variables in PCA but were not highly influential in 
FAN. These findings suggest that the muscle response to injury, 
both with and without shock, is likely driven by a larger number 
of latent factors than in skin.
The high concentrations of MCP-1 seen in the “cardiac arrest 
group” may possibly be caused by the cellular metabolic stress 
associated with cardiac arrest, resulting in insufficient cellular 
perfusion that would then lead to vasodilation, shock, and wide-
spread degranulation of mast cells (83, 84). This chemokine helps 
recruit monocytes, dendritic cells, and memory T cells to sites 
of inflammation. Perhaps more significantly, MCP-1 exerts an 
important role in the degranulation of basophils and mast cells, 
facilitating the release of serine proteases, histamine, serotonin, 
and proteoglycans (70). In turn, mast cell and neutrophil degran-
ulation induced by chemokines, such as MCP-1, and cytokines, 
such as IL-18, releases TNFα, eosinophil chemotactic factor, 
histamine, and a number of other factors (85, 86). This release 
alerts other nearby cells of injury and is a part of the cascade 
that begins the immune response to the injury. This hypothesis 
is supported by evidence that the mast cells are required for 
optimal migration of dendritic cells, swelling, neutrophil infiltra-
tion, and other effects associated with wound healing (87). We 
have recently suggested, through combined in vitro, in silico, and 
clinical studies that liver-derived MCP-1 is a central mediator in 
dynamic networks of inflammation in trauma (31).
In the “cardiac arrest group,” it is likely that the release of 
TNFα as a proapoptotic cytokine was triggered, leading to higher 
concentrations of TNFα in the skin of the “cardiac arrest group.” 
However, the role of TNFα is varied and dependent on a wide 
range of factors, including receptor binding (TNF-R1 vs. TNF-
R2), the local cytokine milieu, the presence of reactive oxygen 
species, as well as many additional factors (88, 89). It is therefore 
not surprising that TNFα is seen also seen in the “injury group” 
although not in as primary a role as in the “cardiac arrest group.”
TNFα also plays a potentially important role as a costimula-
tor of IFNγ production with IL-12 (IL-12p70) (90–92). Levels 
of IFNγ in the skin of the “cardiac arrest group” suggest this as 
an important role of IL-12 in this context but is also capable of 
a variety of immunological capabilities, including stimulating 
proliferation in resting peripheral cells, promoting the generation 
of lymphokine-activated killer cells (LAK cells), and augmenting 
the cytolytic activity of natural killer cells (NK cells) (93–96).
Another prominent cytokine observed in our studies was IL-4, 
which is known to stimulate IgE B cell differentiation as well as 
alternative activation of macrophages into M2 repair cells (97), 
suggesting that IL-4 may be supporting a wound-healing pattern 
in the “injury group.” However, in the “cardiac arrest group,” sig-
nificantly higher concentrations of IL-4, as well as the increased 
presence of additional cytokines that are associated with shock, 
suggest that in this context IL-4 may be acting as a promoter of 
IgE synthesis, contributing to the shock reaction and promoting 
widespread rapid degranulation of PMN leukocytes. Importantly, 
in the “injury group,” high levels of GM-CSF are seen along with 
moderate amounts of IL-4. This same combination of cytokines 
has been shown to enable the maturation of monocytes into 
dendritic cells in vitro (98).
limitations
There are several challenges and limitations in this study. This 
study focuses on the early inflammatory phase following injury and 
therefore does not follow wounds through full healing. Although 
statistically significant differences in the expression levels of multi-
ple inflammatory mediators were found between groups, the study 
size was limited to eight animals (four in the “injury group” and 
four in the “cardiac arrest group”). Additionally, a single time point 
proximal to the time of injury was studied. Future studies would 
ideally extend the findings reported here with larger study groups, 
sampled at multiple longitudinal time points. Our focus on the 
inflammasome was derived from an analysis of a limited number 
of inflammatory mediators. Thus, it is possible that (1) others, 
unmeasured inflammatory mediators play key roles in postinjury 
inflammation and (2) that our analysis methods were insufficient to 
inform our hypotheses. With regard to the former, we attempted to 
focus our analysis on mediators that have been studied previously 
in wound biology. With regard to the latter, we attempted to use 
corroborative methodologies (PCA and FAN) to gain confidence 
in our conclusions. In skin, the agreement between PCA and 
FAN models was high across all measured mediators, providing 
additional evidence that two factors are explanatory. Nonetheless, 
confirmation of this hypothesis requires studies in which the 
inflammasome, caspase-1, IL-1α, and/or IL-18 is antagonized.
cOnclUsiOn
The inflammasome appears to govern the early inflammatory 
response to tissue injury in the skin, releasing proinflammatory 
factors likely to initiate host defense and clearance of debris. 
Normal wound healing is characterized and regulated by char-
acteristic immune signaling patterns, reflected in characteristic 
cytokine and chemokine profiles of skin and muscle (17, 99–102). 
The mediator profile characteristic of an early inflammatory 
response to tissue injury is modified extensively as a result of 
cellular stress induced by shock, likely interfering with eventual 
wound repair and regeneration. Moreover, the inflammatory 
network characteristics of skin and muscle injury responses 
(both with and without severe shock) are recognized as distinct 
from each other, as inferred from data-driven computational 
analyses. These findings support the use of feature transformation 
methods, in combination with literature-based analysis of the 
underlying biological functions, as a method to separate relevant 
biological processes from irrelevant homeostatic processes, or 
other background functions.
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